Leading Cervical Cancer Doctors Support Approval of LuViva i

PEACHTREE CORNERS, Ga., February 20, 2024--Guided Therapeutics, Inc. (OTCQB: GTHP), the maker of the LuViva Advanced Cervical Scan, announced today that a group of prominent cervical cancer doctors are in the final stages of completing the clinical data report that will be submitted for approval by the Chinese National Medical Products Administration (NMPA). The data quality assurance review team is being led by Dr. Sui Long, Director of the Gynecology Hospital at Fudan University and includes p

Related Keywords

Shanghai , China , Chinese , Yaohua Li , Mark Faupel , Qilu Hospital At Shandong University , Gynecology Hospital At Fudan University , Chinese National Medical Products Administration , Shandong Yaohua Medical Instrument Corporation , Therapeutics Inc , Company Chinese , Guided Therapeutics , Luviva Advanced Cervical Scan , Sui Long , Gynecology Hospital , Fudan University , Qilu Hospital , Shandong University , Advanced Cervical Scan , Looking Statements Disclaimer , Guided Therapeutic , Guided Therapeutic Annual Report , Cervical Cancer , Thp , Data Quality Assurance , Tampa , Provinces In China , Ervical Disease ,